Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Eir
  6. /
  7. BioZone Laboratories, Inc.
EIR
•BioZone Laboratories, Inc.•January 26, 2016

BioZone Laboratories, Inc. – FDA EIR, Jan 26, 2016

Record Details

An FDA inspection of Biozone Laboratories Inc., a contract drug manufacturer, was conducted from January 13-26, 2016. This routine surveillance inspection, under the Human Drug CGMP Site Surveillance program and relevant Compliance Program Guidance Manuals, aimed to assess compliance with Good Manufacturing Practices for topical prescription and Over-the-Counter (OTC) drug products. The inspection identified several significant issues, leading to the issuance of a four-item FDA Form 483.Key violations included the quality control unit failing to review and approve laboratory control mechanisms, and inadequate storage conditions for drug products, which could compromise their quality. Additionally, the firm lacked or failed to follow written procedures for instrument calibration and annual batch record evaluations. Beyond the formal observations, verbal discussions highlighted concerns regarding the marketing of unapproved new prescription drugs, such as certain Selenium Sulfide and Sodium Sulfacetamide & Sulfur products, which lacked FDA-approved applications. The firm also appeared to be marketing an OTC pain cream with an active ingredient concentration outside its monograph's typical analgesic classification and a medical device beyond its cleared indications for use. Furthermore, the absence of written quality agreements with some customers for prescription and OTC products was noted. Biozone Laboratories Inc. is required to provide a written response addressing these observations and concerns to the FDA within 15 business days.

Company
BioZone Laboratories, Inc.
Inspection date
January 26, 2016
Product type
drugs
Office
San Francisco District Office
Person
  • Anh M. Lac
View Company Profile

ID · cb4a73f4-1ab2-41ce-8d52-3ae8a2ff02e3

Violation Codes5
21 CFR 211.180(e)(1)21 CFR 211.142(b)21 CFR 211.160(a)21 CFR 820.5021 CFR 211.160(b)(4)

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore BioZone Laboratories, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.